SCHEMBL15075146

SCHEMBL15075146

O=C(O[C@H]1O[C@H](CO)[C@@H](OC(=O)c2ccccc2)[C@H]1O)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ LGALS3 P17931 6/20 0.62
▸ LGALS9 O00182 5/20 0.62
▸ LGALS1 P09382 5/20 0.62
▸ LGALS7; LGALS7B P47929 4/20 0.62
▸ SELP P16109 7/20 0.48
▸ MAOB P27338 1/20 0.47
▸ LGALS8 O00214 4/20 0.47
▸ LGALS4 P56470 1/20 0.45
▸ EPHX2 P34913 1/20 0.44
▸ SELE P16581 1/20 0.44
▸ PTPN1 P18031 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4534423 0.88 LGALS3 (0.58) LGALS3LGALS9LGALS1LGALS7; LGALS7BSELP
SCHEMBL15815859 0.88 LGALS3 (0.58) LGALS3LGALS9LGALS1LGALS7; LGALS7BSELP
SCHEMBL4954660 0.88 LGALS3 (0.58) LGALS3LGALS9LGALS1LGALS7; LGALS7BSELP
SCHEMBL7221498 0.88 LGALS3 (0.58) LGALS3LGALS9LGALS1LGALS7; LGALS7BSELP
SCHEMBL7141014 0.88 LGALS9 (0.61) LGALS3LGALS9LGALS1LGALS7; LGALS7BMAOB
SCHEMBL17318202 0.88 LGALS3 (0.58) LGALS3LGALS9LGALS1LGALS7; LGALS7BSELP
SCHEMBL7144990 0.88 LGALS9 (0.61) LGALS3LGALS9LGALS1LGALS7; LGALS7BMAOB
SCHEMBL6570202 0.88 LGALS9 (0.61) LGALS3LGALS9LGALS1LGALS7; LGALS7BMAOB
SCHEMBL6570199 0.88 LGALS9 (0.61) LGALS3LGALS9LGALS1LGALS7; LGALS7BMAOB
SCHEMBL6507790 0.88 LGALS9 (0.61) LGALS3LGALS9LGALS1LGALS7; LGALS7BMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013096680-A1 SUBSTITUTED PHOSPHOROTHIOATE NUCLEOTIDE ANALOGS ALIOS BIOPHARMA, INC. (US) 2013-06-27 — — WO disclosed
Send feedback